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Abstract
We have evaluated the multiplex molecular method xTAG Gastrointestinal Panel (GPP) for detecting pathogens in stool samples of
diarrhoeic patients. We collected 440 samples from 329 patients (male:female ratio of 1.2:1), including 102 immunosuppressed adults, 50
immunosuppressed children, 56 children attending the neonatal unit and 121 children attending the emergency unit. Of these, 176 samples
from 162 patients were xTAG GPP positive (102 viruses, 61 bacteria and 13 parasites) and the assay was more sensitive than the
conventional test for detecting rotavirus (p <0.01), noroviruses (p <0.0001), Salmonella spp. (p <0.001), Campylobacter spp. (p <0.001) and
toxigenic Clostridium difﬁcile (p 0.005). The predominant pathogens were viruses (23.2%), with rotavirus (15.9%) being the most common.
Bacterial agents were detected in 13.9%; the most common was Salmonella spp. (4.8%). Parasites were detected in 2.9%; Cryptosporidium spp.
(2%) was the most common. There were 31 co-infections (7% of samples), involving two pathogens in 23 (5.2%) and three pathogens in
eight (1.8%) samples. There were 113 (92.6%) positive samples from the children attending the emergency unit, 25 (17%) positive samples
from immunosuppressed adults, 22 (25.3%) positive samples from immunosuppressed children and 16 (19%) positive samples from children
attending the neonatal unit. The low turnaround time and technical hands-on time make this multiplex technique convenient for routine use.
Nevertheless, conventional bacterial culture and parasitological stool examination are still required to detect other pathogens in speciﬁc
cases and to determine susceptibility to antibiotics.
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Introduction
Acute infectious gastroenteritis (AIG) is a major economic
burden in developed countries due to the frequent need to
hospitalize young children and the elderly [1]. Viruses are the
main agents responsible [2] and they often result in outbreaks.
Food-borne bacteria are also a serious public health threat
worldwide. The Shiga-like toxin-producing Escherichia coli
(STEC) (shiga toxin 1 and 2 (stx1/stx2)) has recently joined
the usual enteric pathogenic bacteria such as Salmonella spp.,
Shigella spp. and Yersinia enterocolitica [3]. This pathovar may
cause severe and potentially fatal illnesses such as haemorrhagic
colitis and haemolytic uraemic syndrome (HUS). Bacterial
agents are traditionally identiﬁed by enrichment culture and
biochemical assays, but these techniques are time-consuming.
Oligonucleotide-based microarrays using molecular PCR meth-
ods have been developed that rapidly detect rRNA [4] and
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virulence-factor genes [5] in food, soil and water. These
techniques are also sensitive enough to detect the major
gastrointestinal bacteria in human stool samples [6]. The major
aetiological agents of parasitic diarrhoea are Cryptosporidium
spp., Entamoeba histolytica and Giardia liamblia. Molecular
techniques that are more sensitive and speciﬁc than micros-
copy and antigen detection are also increasingly available [7].
It is difﬁcult to differentiate among viral, bacterial and
parasitic aetiological agents because the symptoms are so
similar. In fact, 80% of all cases of diarrhoea are presently
unidentiﬁed [8], and antibiotics are often used inappropriately.
New molecular techniques can detect bacteria [9], viruses
[10,11] or parasites [7–12] independently or simultaneously
[13]. We have used the xTAG Gastrointestinal Panel (Lum-
inex Molecular Diagnostics, Toronto, ON, Canada) to detect
and identify the majority of microbiological agents of AIG. The
results were compared with those obtained by routine
methods. We also analysed the spread of pathogens among
four populations of patients presenting with AIG: immunosup-
pressed adults, immunosuppressed children, children attending
the neonatal unit and children attending the emergency unit.
Materials and Methods
Sample collection
A total of 440 stool samples prospectively collected from 329
diarrhoeic patients attending the Toulouse University Hospital
from February to December 2011 were sent to the Depart-
ment of Microbiology for investigation. Stool samples were
collected into empty sterile ﬂasks and anorectal swabs were
placed in transport medium (TGV anaerobic, Bio-Rad,
Hercules, CA, USA) for bacterial culture and in virologically
suitable Virocult (Kitvia, Labarthe Inard, France) for virolog-
ical investigation.
Routine diagnostic methods
Rotavirus-adenovirus and noroviruses were detected directly
in stool samples with rapid immunochromatographic tests:
COMBO ROTA ADENO+ STICK (All-Diag, Strasbourg,
France) and Immunocard Norovirus (Meridian Bioscience,
Cincinnati, OH, USA). Minimum essential medium (2 mL) was
then added to each stool sample. These samples were freeze-
thawed to disrupt cells, centrifuged, and the supernatants
saved. Bacteria were cultured from whole stool and anorectal
swabs on each medium plate and selenite broth. Classic enteric
pathogens (Salmonella spp., Campylobacter spp., Yersinia entero-
colitica, Shigella spp., Vibrio cholerae, toxigenic Clostridium difﬁcile,
pathogenic Escherichia coli) were detected by standard culture
methods. Suspicious colonies were identiﬁed using micro-
scopic and biochemical tests. Salmonella serovars were spec-
iﬁed by O and H antigen serotyping. Toxigenic Clostridium
difﬁcile was identiﬁed by immunochromatographic assay
(Immunocard ICTAB, Meridian Bioscience), which identiﬁes
A and B toxins. The virulence genes of toxigenic Escherichia coli
were detected by multiplex PCR (Genotype EHEC, Hain
LifeScience, Nehren, Germany) from Enterobacteria colonies
[14]. Different protocols were used to analyse the stools of
children and adults. We looked for toxigenic Clostridium difﬁcile
and Escherichia coli pathovars in all the samples from children,
but only in those from certain adults: post-antibiotherapy
diarrhoea and nosocomial outbreaks for toxigenic Clostridium
difﬁcile, or an epidemiological infection for STEC. A routine
stool culture usually took 72 h or longer to complete.
We looked for protozoa (Entamoeba histolytica and Giardia
liamblia) by microscopic examination of fresh stools and of
samples ﬁxed/concentrated with merthiolate-iodine-formalde-
hyde (MIF). Cryptosporidium spp. was detected by a modiﬁed
Zielh–Neelsen and auramine staining method [15].
Molecular diagnostic assay
Total nucleic acids were extracted from the stool supernatants
with the MagNA Pure 96TM DNA and Viral NA Small Volume Kit
(Roche Molecular Diagnosis, Meylan, France) on the MagNA
Pure 96. Input and output volumes were 200 and 100 lL.
The multiplex xTAG Gastrointestinal Panel was used to
detect 15 microbiological gastrointestinal pathogens or toxins:
rotavirus A, adenoviruses 40 and 41, noroviruses GI and GII,
Salmonella spp., Shigella spp., Campylobacter spp., Clostridium
difﬁcile toxin A/toxin B, STEC, Enterotoxinogenic Escherichia
coli heat stable and heat labile toxin (ST/LT) (ETEC), enter-
ohaemorragic Escherichia coli O157 (EHEC), Yersinia enterocol-
itica, Vibrio cholerae, Giardia liamblia, Cryptosporidium spp. and
Entamoeba histolytica. Multiplex RT-PCR was performed on a
GeneAmp 9700 ABI thermocycler (Applied Biosystems, Santa
Clara, CA, USA) using 10 lL of nucleic acid. Biotin-tagged
amplicons were generated if a pathogen was present. Anti-tags
coupled to colour-coded beads generated a bead-amplicon
complex subsequently detected on the Luminex200 reading
system. An internal control (bacteriophage MS2) was included
in each specimen. Raw data were analysed with the TDAS GPP
version 1.11 (xTAG Data Analysis Software): positive and
negative results were linked to a ratio between the target
median ﬂuorescence intensity (MFI) and the threshold. Sam-
ples showing discrepant adenovirus results were tested on the
Light Cycler 2.0TM using an in-house real-time PCR [16].
Statistics
Data were analyzed using StataTM software (StataCorp,
Houston, TX, USA). The match between the assays was
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assessed using the Mc Nemar chi-squared test. p-values of
<0.05 were considered signiﬁcant.
Results
Four hundred and forty stool samples were prospectively
collected from 329 diarrhoeic patients (male:female ratio,
1.2:1). Three groups included immunosuppressed hospitalized
patients: 102 adult organ transplant recipients (mean age, 50.6;
median, 56; range, 17–75), 50 immunosuppressed children
(mean age, 5; median, 7; range, 0–14) and 56 children attending
the neonatal unit (aged under 1 year). The 121 children
attending the emergency unit (mean age, 2.80; median, 9;
range, 0–16) were considered to be outpatients.
Pathogens detected with the xTAG GPP
We found 176 (40%) positive samples collected from 162
patients (Fig. 1). Of these, 102 samples were positive for
viruses, with rotavirus being the most common (70 samples;
15.9%), followed by norovirus (30 samples; 6.8%). Adeno-
viruses were detected in two samples. Bacterial agents were
detected in 61 (13.9%) samples. Salmonella spp. was the most
common (21 samples; 4.8%), followed by toxigenic Clostridium
difﬁcile (18 samples; 4.1%) and Campylobacter spp. (13 samples;
2.9%). STEC was detected in seven (1.6%) samples. One
sample was positive for Shigella spp. and one was positive for
the O157 Escherichia coli serovar. Parasites were detected in
13 (2.9%) samples, with Cryptosporidium spp. being the most
common (nine samples, 2%). Three samples were positive for
Entamoeba histolytica and one for Giardia liamblia.
Children attending the emergency unit
Rotavirus: 56.6% Adenovirus: 0.8% Norovirus: 13.1%
Salmonella spp: 10.7% Toxigenic Clostridium difficile: 1.6% Campylobacter jejuni: 3.3 %
Shigella spp: 0.8 % Shiga toxin Escherichia coli: 0.8 % Escherichia coli O157: 0.8 % 
Cryptosporidium: 1.6 %  Entamoeba histolytica: 1.6 % Giardia liamblia: 0.8 %
Negative: 7.5%
(a)
Immunocompromised children
Rotavirus: 1.1% Adenovirus: 1.1%
Norovirus: 9.2% Salmonella spp: 3.4% 
Toxigenic Clostridium difficile: 3.4% Shiga toxin Escherichia coli: 3.4%
Cryptosporidium: 3.4%  Negative: 74.7%
(c)
Immunocompromised adults
Norovirus: 4.1% Salmonella spp: 2.7% 
Toxigenic Clostridium difficile: 7.5% Campylobacter jejuni: 0.7%
Shiga toxin Escherichia coli: 1.4% Cryptosporidium: 0.7% 
Negative: 83%
(b)
Children from neonatal unit
Salmonella spp: 1.2% Toxigenic Clostridium difficile: 2.4%
Campylobacter jejuni: 9.5% Shiga toxin Escherichia coli: 1.2%
Cryptosporidium: 3.6% Entamoeba histolytica: 1.2%
Negative: 81%
(d)
FIG. 1. (a) Pathogens in 113 samples collected from the 121 children (21 co-infections). (b) Pathogens (n = 25) detected among the 102 adult
immunocompromised patients attending the emergency unit (three co-infections). (c) Pathogens (n = 22) detected among the 50 immunocom-
promised children (four co-infections). (d) Pathogens (n = 16) detected among the 56 children attending the neonatal unit (three co-infections).
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There were 31 co-infections (7% of samples) of viruses and/
or bacteria and/or parasites (Table 1). Co-infections involved
two pathogens in 23 (5.2%) samples and three pathogens in
eight (1.8%) samples.
Comparison of the xTAG GPP and conventional detection
The two methods were compared using the data from samples
tested by both techniques (Table 2).
Virological results. The xTAG GPP detected more viruses than
did conventional methods: for norovirus, 6.8% (30/440 sam-
ples) were positive compared with 0.3% (1/287 sample) using
conventional testing (p <0.0001); for rotavirus, 15.9% (70/440
samples) were positive compared with 14.4% (63/438 samples)
using the conventional detection (p <0.01). For adenovirus,
0.4% (2/440 samples) were positive using the xTAG GPP and
negative using conventional technique.
The immunochromatographic technique detected norovirus
in one sample, rotavirus in two samples and adenovirus in ﬁve
samples that were negative with the xTAG GPP.
Samples giving discordant adenovirus results were tested
with the in-house real-time PCR: this gave results similar to
those of xTAG GPP.
Bacteriological results. The xTAG GPP identiﬁed 61 (13.9%)
samples that contained bacteria, while conventional methods
identiﬁed only 21. Toxigenic Clostridium difﬁcile was detected in
18/440 samples (4.1%) by xTAG GPP, and in 1.3% (5/372
samples; p 0.005) by conventional methods. The corresponding
ﬁgures for Salmonella spp. were 21/440 (4.8%) and 9/413 (2.2%;
p <0.001); for Campylobacter spp. they were 13/440 (2.9%) and
1/415 (0.2%; p <0.001), and for STEC they were 7/440 (1.6%)
and 5/273 (1.8%; ns). Both techniques detected one sample
containing Shigella spp.,while the xTAGGPPdetected onewith
Escherichia coli O157 serovar. Neither technique detected any
samples containing ETEC, Yersinia enterocolitica or Vibrio cholerae.
The conventional technique detected Salmonella spp. in two
samples that were negative with the xTAG GPP.
Parasitological results. The xTAG GPP detected parasites in 13
stool samples; only one of these was tested with a conven-
tional technique and it was negative. Cryptosporidium spp. was
found in nine samples, Entamoeba histolytica in three samples
and Giardia liamblia in one sample. The samples that were
positive for Entamoeba histolytica gave an MFI value close to the
threshold.
Overall, the xTAG GPP system identiﬁed 34 samples that
tested negative for pathogens and the internal control
(uninterpretable results). These samples were either negative
or not tested by routine techniques. T
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Epidemiological features
Most of the samples (113/122; 92.6%) collected from the
children attending the emergency unit tested positive,
while there were fewer positive samples among those
collected from immunosuppressed adults (25/147;
17%), from immunosuppressed children (22/87; 25.3%),
TABLE 2. Results of the xTAG-GPP assay and conventional detection.
Pathogen Routine test
Conventional routine detection
Total Mc Nemar chi-squared test: pPositive (N) Negative (N) Not done (N)
xTAG results Rotavirus
Positive COMBO ROTA ADENO+ STICK 61 9 0 70 0.008
Negative 2 332 2 336
No call 0 34 0 34
Total 63 375 2 440
Norovirus GI and GII
Positive Immunocard Norovirus 0 17 13 30 <0.0001
Negative 1 250 125 376
No call 0 19 15 34
Total 1 286 153 440
Adenovirus 40 and 41
Positive COMBO ROTA ADENO+ STICK 0 2 0 2 ns
Negative 5 396 3 404
No call 0 34 0 34
Total 5 432 3 440
Campylobacter spp.
Positive Standard culture 1 12 0 13 <0.001
Negative 0 368 25 393
No call 0 34 0 34
Total 1 414 25 440
Salmonella spp.
Positive Standard culture 7 14 0 21 <0.001
Negative 2 356 27 385
No call 0 34 0 34
Total 9 404 27 440
Shigella spp.
Positive Standard culture 1 0 0 1 ns
Negative 0 378 27 405
No call 0 34 0 34
Total 1 412 27 440
Toxigenic Clostridium difﬁcile toxin A and B
Positive PCR 5 8 5 18 0.005
Negative 0 331 57 388
No call 0 28 6 34
Total 5 367 68 440
Shiga-like toxin producing Escherichia coli shiga (toxin 1 and 2 (stx1/stx2) (STEC)
Positive PCR 5 2 0 7 ns
Negative 0 258 141 399
No call 0 8 26 34
Total 5 268 167 440
Enterotoxigenic Escherichia coli heat stable and heat labile toxin (ETEC)
Positive PCR 0 0 0 0
Negative 0 266 140 406
No call 0 8 26 34
Total 0 274 166 440
Escherichia coli O157
Positive PCR 0 1 0 1
Negative 0 265 140 405
No call 0 8 26 34
Total 0 274 166 440
Yersinia enterocolitica
Positive Standard culture 0 0 0 0
Negative 0 379 27 406
No call 0 34 0 34
Total 0 413 27 440
Vibrio cholerae
Positive Standard culture 0 0 0 0
Negative 0 379 27 406
No call 0 34 0 34
Total 0 413 27 440
Giardia liamblia
Positive Microscopic examination 0 0 1 1
Negative 0 118 287 405
No call 0 8 26 34
Total 0 126 314 440
Cryptosporidium spp.
Positive Microscopic examination 0 1 8 9
Negative 0 117 280 397
No call 0 8 26 34
Total 0 126 314 440
Entamoeba histolytica
Positive Microscopic examination 0 0 3 3
Negative 0 118 285 403
No call 0 8 26 34
Total 0 126 314 440
ns, not signiﬁcant; no call, uninterpretable results.
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and from children attending the neonatal unit (16/84; 19%)
(Fig. 1a–d).
Nevertheless, the distribution of the pathogens differed
from one patient population to another; 98.6% (69/70) of
rotavirus and 53.3% (16/30) of norovirus were detected in the
samples from children attending the emergency unit. Norovi-
rus was also detected in 26.7% of the samples (8/30) from
immunocompromised children and in 20% of those from adults
(6/30). Salmonella spp. was detected most frequently in samples
from children attending the emergency unit (13/21; 61.9%),
while toxigenic Clostridium difﬁcile was most common in those
from immunocompromised adults (11/18; 61.1%).
Discussion
Four hundred and forty stool samples collected from 329
diarrhoeal patients were analysed to evaluate the performance
of the xTAG GPP. The rates of detection were compared
with those obtained with routine diagnosis techniques. We
also determined the prevalence of pathogens in four popula-
tions of patients.
The multiplex PCR technique was statistically more sensi-
tive than conventional techniques and allowed the aetiological
diagnosis of some cases of gastroenteritis whose origin had
been previously unknown. This was especially the case for
norovirus, Salmonella spp., Campylobacter spp. and Cryptospori-
dium spp. This is comparable with the results of the large
longitudinal study by Tam et al. [17] conducted in the United
Kingdom: norovirus was the most common organism detected
and Campylobacter spp. the most common bacterium. Novel
diagnostic techniques have led to a new appreciation of the
impact of noroviruses on AIG. They can be responsible for
about 90% of previously undetermined outbreaks of gastro-
enteritis and 5–30% of cases of sporadic childhood and adult
gastroenteritis [17–19]. Norovirus has now spread to health-
care environments worldwide, including both immunocompe-
tent and immunocompromised children and adults [20]. These
published data are similar to our results; we detected
noroviruses in children attending the emergency unit, and also
in immunocompromised adults and children.
The xTAG GPP did not detect rotavirus in two samples,
adenovirus in ﬁve samples and norovirus in one sample that
were positive with the immunochromatographic tests. These
manual techniques include steps that might be dependent on
the technician. Positive adenovirus samples were tested with a
second molecular test that gave results similar to those of the
xTAG GPP. Molecular techniques are likely to be highly
speciﬁc as they use speciﬁc primers and probes. These results
show that immunochromatographic tests can give false-
positive results and do not mean that the xTAG GPP was
less sensitive.
The xTAG GPP detected more bacteria than did conven-
tional methods. Only two samples showed discrepant results
for Salmonella spp. (positive by standard culture and negative
with the xTAG GPP). The samples in question were positive
for Salmonella enteritidis and Salmonella typhi murium. These
pathogens have been detected in other samples that were
positive by both techniques, indicating that the xTAG GPP
was well designed to detect them. These discrepant results
were probably due to stochastic detection of the pathogens in
these samples. These results are similar to those of a previous
study using the Seeplex diarrhoea ACE detection system
[13]: three samples were not detected by the molecular test.
We routinely tested samples from children for toxigenic
Clostridium difﬁcile because numerous surveys and studies
looking at the signiﬁcance of isolating this pathogen have
demonstrated its pathogenic potential in children [21,22].
Cancer chemotherapy also seems to be as important as
antibiotics in Clostridium difﬁcile infection in paediatric inpa-
tients and outpatients.
One sample that tested negative for shigatoxin genes was
positive for the Escherichia coli O157 serovar, indicating that
the serotype O157 is not necessarily related to the virulence
of Escherichia coli [14]. The seven samples that tested positive
for shigatoxins genes were negative for O157 serovar,
indicating that STEC belong to serovars other than O157.
Neither ETEC nor Yersinia enterocolitica were detected, which
is well in accordance with the epidemiological spread of these
bacteria: ETEC is a gastrointestinal pathogen in developing
countries [23] and there is evidence that the spread of Yersinia
enterocolitica is decreasing [24].
Studies comparing PCR with microscopic examination for
protozoa have shown that conventional techniques lack
sensitivity. However, we tested only a few samples by
conventional methods, making the results difﬁcult to interpret.
Entamoeba histolytica was detected in stool samples of one child
attending the neonatal unit and in those of two children
attending the emergency unit. All three gave a slightly positive
signal. These results are difﬁcult to interpret in the absence of a
reference technique, and might reﬂect false-positive reactivity.
The xTAG GPP method efﬁciently detected co-infections
and the results are in agreement with those of previously
published studies that detected rates of co-infections of 0.9%
(0.02% by conventional methods) [25] and 6.8% (0% by
conventional methods) [26]. Other studies on patients with
AIG requiring hospitalization have shown very high rates of
co-infection (up to 22%) [27,28].
The present study provides a clear picture of the relative
frequencies of microbiological pathogens in different patient
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populations. Children attending the emergency unit were
more frequently infected with a wider diversity of pathogens
than were the three other hospitalized populations. Rotavirus,
norovirus and Salmonella spp. were detected mainly in these
children. This is not surprising as the children’s emergency unit
takes in children presenting with AIG requiring a medical
examination. Similarly, in adults, Jansen et al. [28] detected
Campylobacter spp. (35%) most frequently, but also norovirus
(23%), Salmonella spp. (20%) and rotavirus (15%). Cryptospori-
dium spp. was mainly detected in children <5 years old: this is
similar to results reported by Yoder et al. [29] in the United
States.
Most of the samples from the other three hospitalized
groups of patients were negative: toxigenic Clostridium difﬁcile
was the most prominent pathogen in those that were positive.
This is comparable to the results of Raines, who showed that
this pathogen is a major cause of AIG in non-HIV immunosup-
pressed patients [30]. No viruses were detected in samples
from children attending the neonatal unit. The AIG of most of
the hospitalized patients was due to factors other than
infections, for example the therapy itself in transplant recipients.
This new technique dramatically shortens turnaround time:
approximately 4 h are needed to provide the results for 15
pathogens. Conventional techniques require at least 2 days,
involve many and various technical steps and need a range of
technical competences (culture, PCR and microscopy). Like
Taniucchi et al. [9] we have clearly shown that total nucleic
acid extracted directly from stool samples can be used for
molecular diagnosis; all microbiological pathogens can be
detected in a single test, leading to a dramatic decrease of
hands-on time. The xTAG GPP reagents are relatively
expensive, but certainly cheaper than the total cost of all the
various reagents and the technicians’ time required to obtain
the same performance. However, this was not evaluated
precisely as it was not the aim of the study.
The major limitation of the present study is that some
samples were not tested with all the techniques. This may
induce a bias, especially in the interpretation of the parasito-
logical results. However, analysis of the available results shows
that this new technique was more sensitive than the conven-
tional techniques and that less time was required to obtain
similar results.
In conclusion, the multiplex-PCR luminex bead assay is a
very sensitive and convenient method for detecting multiple
gastrointestinal microbiological pathogens from a single stool
sample and may be easily used in routine daily practice.
However, some pathogens responsible for food toxi-infections
are not detected, including the enteropathogen Escherichia coli
(EPEC), Clostridium perfringes, the enteropathogen Staphylococ-
cus aureus, and toxigenic Aeromonas. We propose the following
workﬂow pattern. Step one: use the xTAG-GPP to obtain
results for viruses and to identify the main bacterial and
parasitological pathogens. Step two: set up bacterial cultures,
depending on the results obtained, to determine the antibiotic
susceptibility of xTAG-GPP-positive samples or to identify
other bacteria in xTAG-GPP-negative samples. Stool samples
should only be examined for parasites in speciﬁc clinical and
epidemiological contexts that might involve parasites not
detected by the xTAG-GPP technique.
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